Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths | Addiction Medicine | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Okie S. A flood of opioids, a rising tide of deaths.  N Engl J Med. 2010;363(21):1981-198521083382PubMedGoogle ScholarCrossref
 Web-based Injury Statistics Query and Reporting System: leading causes of death reports. Centers for Disease Control and Prevention. Accessed March 4, 2011
Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States.  Pharmacoepidemiol Drug Saf. 2006;15(9):618-62716862602PubMedGoogle ScholarCrossref
Dunn KM, Saunders KW, Rutter CM,  et al.  Opioid prescriptions for chronic pain and overdose: a cohort study.  Ann Intern Med. 2010;152(2):85-9220083827PubMedGoogle ScholarCrossref
Chou R, Fanciullo GJ, Fine PG,  et al; American Pain Society–American Academy of Pain Medicine Opioids Guidelines Panel.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.  J Pain. 2009;10(2):113-13019187889PubMedGoogle ScholarCrossref
McLellan AT, Turner B. Prescription opioids, overdose deaths, and physician responsibility.  JAMA. 2008;300(22):2672-267319066389PubMedGoogle ScholarCrossref
Portenoy RK, Messina J, Xie F, Peppin J. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study.  Curr Med Res Opin. 2007;23(1):223-23317207304PubMedGoogle ScholarCrossref
Simpson DM, Messina J, Xie F, Hale M. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.  Clin Ther. 2007;29(4):588-60117617282PubMedGoogle ScholarCrossref
 VA/DoD Clinical Practice Guideline: management of opioid therapy for chronic pain [2010].  Department of Veterans Affairs, Department of Defense. Accessed March 4, 2011
Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials.  Biometrika. 1986;73:1-11Google ScholarCrossref
Lash TL, Cole SR. Immortal person-time in studies of cancer outcomes.  J Clin Oncol. 2009;27(23):e55-e5619597013PubMedGoogle ScholarCrossref
Suissa S. Immortal time bias in pharmaco-epidemiology.  Am J Epidemiol. 2008;167(4):492-49918056625PubMedGoogle ScholarCrossref
 National Death Index. Centers for Disease Control and Prevention. Accessed March 4, 2011
Cowper DC, Kubal JD, Maynard C, Hynes DM. A primer and comparative review of major US mortality databases.  Ann Epidemiol. 2002;12(7):462-46812377423PubMedGoogle ScholarCrossref
McCarthy JF, Valenstein M, Kim HM, Ilgen M, Zivin K, Blow FC. Suicide mortality among patients receiving care in the Veterans Health Administration health system.  Am J Epidemiol. 2009;169(8):1033-103819251753PubMedGoogle ScholarCrossref
Sohn MW, Arnold N, Maynard C, Hynes DM. Accuracy and completeness of mortality data in the Department of Veterans Affairs.  Popul Health Metr. 2006;4:216606453PubMedGoogle ScholarCrossref
Wysowski DK. Surveillance of prescription drug-related mortality using death certificate data.  Drug Saf. 2007;30(6):533-54017536879PubMedGoogle ScholarCrossref
Gammaitoni AR, Fine P, Alvarez N, McPherson ML, Bergmark S. Clinical application of opioid equianalgesic data.  Clin J Pain. 2003;19(5):286-29712966254PubMedGoogle ScholarCrossref
Prommer E. Oxymorphone: a review.  Support Care Cancer. 2006;14(2):109-11516317569PubMedGoogle ScholarCrossref
Lawlor PG, Turner KS, Hanson J, Bruera ED. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.  Cancer. 1998;82(6):1167-11739506365PubMedGoogle ScholarCrossref
Valenstein M, Taylor KK, Austin K, Kales HC, McCarthy JF, Blow FC. Benzodiazepine use among depressed patients treated in mental health settings.  Am J Psychiatry. 2004;161(4):654-66115056511PubMedGoogle ScholarCrossref
Langholz B, Jiao J. Computational methods for case-cohort studies.  Comput Stat Data Anal. 2007;51(8):3737-3748Google ScholarCrossref
Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain.  Pain. 1999;81(1-2):129-13410353500PubMedGoogle ScholarCrossref
Lo B, Rubenfeld G. Palliative sedation in dying patients: “we turn to it when everything else hasn't worked.”  JAMA. 2005;294(14):1810-181616219885PubMedGoogle ScholarCrossref
Hall AJ, Logan JE, Toblin RL,  et al.  Patterns of abuse among unintentional pharmaceutical overdose fatalities.  JAMA. 2008;300(22):2613-262019066381PubMedGoogle ScholarCrossref
Schumann H, Erickson T, Thompson TM, Zautcke JL, Denton JS. Fentanyl epidemic in Chicago, Illinois and surrounding Cook County.  Clin Toxicol (Phila). 2008;46(6):501-50618584361PubMedGoogle ScholarCrossref
Donaldson AE, Larsen GY, Fullerton-Gleason L, Olson LM. Classifying undetermined poisoning deaths.  Inj Prev. 2006;12(5):338-34317018678PubMedGoogle ScholarCrossref
Original Contribution
April 6, 2011

Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths

Author Affiliations

Author Affiliations: Department of Veterans Affairs, Health Services Research & Development (HSR&D) Center of Excellence, and Serious Mental Illness Treatment Resource and Evaluation Center, Ann Arbor, Michigan (Drs Bohnert, Valenstein, McCarthy, Ilgen, and Blow and Ms Ganoczy); Department of Psychiatry, University of Michigan Medical School, Ann Arbor (Drs Bohnert, Valenstein, McCarthy, Ilgen, and Blow and Ms Ganoczy); Department of Veterans Affairs, HSR&D Center of Excellence, Indianapolis, Indiana (Dr Bair), and Department of Medicine, Indiana University School of Medicine, Indianapolis (Dr Bair).

JAMA. 2011;305(13):1315-1321. doi:10.1001/jama.2011.370

Context The rate of prescription opioid–related overdose death increased substantially in the United States over the past decade. Patterns of opioid prescribing may be related to risk of overdose mortality.

Objective To examine the association of maximum prescribed daily opioid dose and dosing schedule (“as needed,” regularly scheduled, or both) with risk of opioid overdose death among patients with cancer, chronic pain, acute pain, and substance use disorders.

Design Case-cohort study.

Setting Veterans Health Administration (VHA), 2004 through 2008.

Participants All unintentional prescription opioid overdose decedents (n = 750) and a random sample of patients (n = 154 684) among those individuals who used medical services in 2004 or 2005 and received opioid therapy for pain.

Main Outcome Measure Associations of opioid regimens (dose and schedule) with death by unintentional prescription opioid overdose in subgroups defined by clinical diagnoses, adjusting for age group, sex, race, ethnicity, and comorbid conditions.

Results The frequency of fatal overdose over the study period among individuals treated with opioids was estimated to be 0.04%.The risk of overdose death was directly related to the maximum prescribed daily dose of opioid medication. The adjusted hazard ratios (HRs) associated with a maximum prescribed dose of 100 mg/d or more, compared with the dose category 1 mg/d to less than 20 mg/d, were as follows: among those with substance use disorders, adjusted HR = 4.54 (95% confidence interval [CI], 2.46-8.37; absolute risk difference approximation [ARDA] = 0.14%); among those with chronic pain, adjusted HR = 7.18 (95% CI, 4.85-10.65; ARDA = 0.25%); among those with acute pain, adjusted HR = 6.64 (95% CI, 3.31-13.31; ARDA = 0.23%); and among those with cancer, adjusted HR = 11.99 (95% CI, 4.42-32.56; ARDA = 0.45%). Receiving both as-needed and regularly scheduled doses was not associated with overdose risk after adjustment.

Conclusion Among patients receiving opioid prescriptions for pain, higher opioid doses were associated with increased risk of opioid overdose death.